Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023

Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.

NASH is most common in patients who are overweight or obese and other risk factors include diabetes, high cholesterol, high triglycerides, poor diet, metabolic syndrome, polycystic syndrome, sleep apnea, underactive thyroid (hypothyroidism).

Read more about Non-Alcoholic Steatohepatitis (NASH) market here: https://www.globalinsightservices.com/reports/non-alcoholic-steatohepatitis-nash-drug-pipeline-landscape/

There are currently several clinical trials underway for potential treatments for NASH. These include trials testing medications that target specific aspects of the disease, such as inflammation or insulin resistance, as well as more general trials testing treatments that aim to improve overall liver function. Many of these trials are still in the early stages, but some have already shown promising results.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS31203

Key Players
180 Life Corp
89bio, Inc.
Acquist Theraputics Inc
Akero Therapeutics, Inc
Algernon Pharmaceuticals Inc
Aligos Therapeutics
Allysta Pharmaceuticals Inc
Altay Therapeutics Inc
Altimmune, Inc.
Amgen

Report Segmentation
Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration

Get Customized Report as Per Your Requirement -https://www.globalinsightservices.com/request-customization/GIS31203

Report Highlights
Global Insight Service's, Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023 report provides an overview of the Non-alcoholic steatohepatitis pipeline drugs. This report covers detailed insights on Nonalcoholic Steatohepatitis (NASH) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Nonalcoholic Steatohepatitis (NASH) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/inquiry-before-buying/GIS31203

With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.

This release was published on openPR.